Does USTEKINUMAB Cause C-reactive protein increased? 1,280 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,280 reports of C-reactive protein increased have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.5% of all adverse event reports for USTEKINUMAB.
1,280
Reports of C-reactive protein increased with USTEKINUMAB
1.5%
of all USTEKINUMAB reports
773
Deaths
902
Hospitalizations
How Dangerous Is C-reactive protein increased From USTEKINUMAB?
Of the 1,280 reports, 773 (60.4%) resulted in death, 902 (70.5%) required hospitalization, and 650 (50.8%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,280 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which USTEKINUMAB Alternatives Have Lower C-reactive protein increased Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE